Skip to content

Insider · CIK 0001856414

Tina Marriott

coopresidentofficer

Files at RXRX (RECURSION PHARMACEUTICALS, INC.). First filing Oct 28, 2024, latest Oct 28, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $38k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RXRX: RECURSION PHARMACEUTICALS, INC.

RXRXOct 9, 2026 · close 4.36

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
0Weak
RXRXsell 210b5-1
RECURSION PHARMACEUTICALS, INC.
$38k
6,000 shares
-1%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 15, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
FTax withholding
Class A Common Stock
-14,286$6.18$88k506,852Nov 19, 2024
Oct 24, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
MOption exercise
Class A Common Stock10b5-1
+6,000$1.06$6,360527,138Oct 28, 2024
Oct 24, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
SOpen-market sale
Class A Common Stock10b5-1
-6,000$6.31$38k521,138Oct 28, 2024
Oct 24, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-6,000$0.00$0452,000Oct 28, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Tina Marriott: insider trades and track record | InsiderTell